DAVID WICKER: Open Payments
NPI 1306476957 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,517 in 170 payments from 23 companies in 2025. Trend: 2023 $738 · 2024 $2,275 · 2025 $3,517
Food & beverage: $3,417Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $356 |
| GlaxoSmithKline, LLC. | 20 | $285 |
| Electromed, Inc. | 10 | $278 |
| Insmed, Inc. | 11 | $263 |
| United Therapeutics Corporation | 9 | $233 |
| GENZYME CORPORATION | 8 | $206 |
| Regeneron Healthcare Solutions, Inc. | 10 | $203 |
| HARMONY BIOSCIENCES LLC | 8 | $202 |
| Vifor Pharma, Inc. | 16 | $196 |
| Mallinckrodt Hospital Products Inc. | 7 | $196 |
Products named: DUPIXENT, SMARTVEST, Arikayce, Tyvaso, WAKIX, ACTHAR, NUCALA, Zemaira.
Industry payments across AR — which companies pay providers there.
